Search

everythinglearnresearchcommunity

for

Search:↓

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some breast cancer chemotherapy can cause permanent hair loss.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Doctors need to be better prepared to assess and treat obesity in patients.

Dandruff is a common, winter-worsened scalp condition linked to inflammation and microorganisms, treatable with products like ketoconazole, and may affect hair loss.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.